RVTY

Revvity Inc. provides products services and solutions to the diagnostics life sciences and applied services markets worldwide. It operates through two segments Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments reagents informatics software subscriptions detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market as well as contract research and laboratory services. It also provides analytical technologies solutions and services for its customers to understand the characterize the health of various aspects including air water and soil. In addition this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market which includes the chemical semiconductor and electronics energy lubricant petrochemical and polymer industries. The Diagnostics segment provides instruments reagents assay platforms and software products for the early detection of genetic disorders such as pregnancy and early childhood as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities disorders and diseases including down syndrome hypothyroidism muscular dystrophy infertility and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology immunodiagnostics and drug discovery. It serves pharmaceutical and biotechnology companies laboratories academic and research institutions public health authorities private healthcare organizations doctors and government agencies. The company was formerly known as PerkinElmer Inc. and changed its name to Revvity Inc. in April 2023. Revvity Inc. was founded in 1937 and is headquartered in Waltham Massachusetts.